Pacific Biosciences Of California PACB Income Statement (2010-2026)

NASDAQ PACB
$1.29 -0.03 (-2.27%)
As of: Sep 9, 2026 · 1:43 PM EDT
Reported Financials

Pacific Biosciences Of California Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Pacific Biosciences Of California reported revenue of $39.01M and net income of -$45.10M for the quarter ended Jun 2026, down 1.9% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
36.02M33.17M35.47M32.31M27.35M38.90M47.57M55.69M58.36M38.81M36.01M39.97M39.22M37.15M39.77M38.44M44.65M37.18M39.01M
Cost of RevenueCost of Rev
19.25M19.02M19.27M18.76M22.21M29.14M32.03M37.79M48.79M27.53M30.07M29.96M29.17M38.52M25.08M22.54M28.08M24.34M26.37M
Gross Profit
16.77M14.15M16.19M13.55M5.14M9.76M15.55M17.90M9.57M11.28M5.94M10.00M10.06M-1.37M14.68M15.90M16.57M12.84M12.64M
Operating items
Amortization - Intangibles
0.18M0.18M0.18M0.73M0.18M0.18M0.74M5.42M5.51M4.22M3.65M4.63M362.04M0.83M0.83M0.83M0.83M0.83M
Depreciation & Amortization - TotalDep. & Amort. (Tot)
2.27M2.32M2.35M2.56M2.75M2.83M2.90M3.01M3.24M3.50M4.19M2.87M5.13M2.66M2.46M2.75M2.20M2.32M
Research & DevelopmentR&D
42.58M52.94M50.35M47.09M42.62M48.94M46.17M47.51M44.54M43.45M38.48M25.52M27.47M29.05M22.53M22.85M22.88M19.61M23.02M
Selling, General & AdministrativeSG&A
37.32M39.80M39.25M36.80M45.00M39.82M40.57M43.43M46.00M43.75M45.88M43.75M41.64M40.17M36.17M31.10M34.05M31.15M33.39M
Restructuring CostsRestructuring
12.00M0.40M8.98M0.06M
Other Operating ExpensesOther Opex
-3.33M-7.76M1.93M2.04M9.50M-0.85M-2.43M3.50M2.20M93.92M0.63M91.11M-1.63M-1.92M45.80M
Operating ExpensesOpex
12.00M81.44M91.68M84.16M88.17M92.22M101.01M88.72M100.39M97.12M92.64M181.78M74.08M163.09M427.56M59.54M54.78M57.76M21.20M57.25M
Operating IncomeOp. Inc
-64.68M-77.52M-67.97M-74.62M-87.08M-91.25M-73.17M-82.49M-87.55M-81.36M-175.85M-64.08M-153.03M-428.93M-44.85M-38.88M-41.20M-8.36M-44.61M
EBIT
-64.68M-77.52M-67.97M-74.62M-87.08M-91.25M-73.17M-82.49M-87.55M-81.36M-175.85M-64.08M-153.03M-428.93M-44.85M-38.88M-41.20M-8.36M-44.61M
Non-operating items
Non Operating Interest Expenses
3.48M3.70M3.68M3.66M3.65M3.63M3.55M3.59M3.57M3.58M3.54M3.54M2.76M1.74M1.74M1.74M1.74M1.74M2.11M
Interest & Investment IncomeInt & Inv Inc
Other Non Operating IncomeOther Non Op Inc.
0.00M-0.28M0.26M1.31M6.35M6.87M8.93M8.51M8.38M6.76M6.07M6.89M134.69M4.29M4.70M3.00M2.77M2.01M2.04M
Net income details
EBT
-68.15M-81.50M-71.39M-76.97M-84.38M-88.02M-69.83M-77.58M-82.74M-78.18M-173.32M-60.73M2.69M-426.38M-41.90M-37.62M-40.17M-8.09M-44.68M
Tax ProvisionsTaxes
1.18M-10.71M-0.72M0.32M-0.30M0.04M0.38M0.20M0.18M0.06M
Profit After TaxPAT
-70.44M-84.50M-72.77M-77.77M-82.89M-88.02M-70.59M-66.87M-82.02M-78.70M-173.54M-60.73M2.37M-426.12M-42.04M-38.00M-40.36M-8.88M-45.10M
Income from Continuing OperationsIncome (Continuing)
-69.33M-81.50M-71.39M-76.97M-84.38M-88.02M-69.83M-66.87M-82.02M-78.18M-173.32M-60.73M2.37M-426.07M-41.93M-38.00M-40.37M-8.28M-44.74M
Consolidated Net IncomeConsol Net Inc.
-69.33M-81.50M-71.39M-76.97M-84.38M-88.02M-69.83M-66.87M-82.02M-78.18M-173.32M-60.73M2.37M-426.07M-41.93M-38.00M-40.37M-8.28M-44.74M
Income towards Parent CompanyParent Net Inc
-69.33M-81.50M-71.39M-76.97M-84.38M-88.02M-69.83M-66.87M-82.02M-78.18M-173.32M-60.73M2.37M-426.07M-41.93M-38.00M-40.37M-8.28M-44.74M
Net Income towards Common StockholdersNet Income
-69.33M-81.50M-71.39M-76.97M-84.38M-88.02M-69.83M-66.87M-82.02M-78.18M-173.32M-60.73M2.37M-426.07M-41.93M-38.00M-40.37M-8.28M-44.74M
Additional items
EPS (Basic)
-0.34-0.37-0.32-0.34-0.38-0.36-0.28-0.26-0.32-0.29-0.64-0.220.01-1.44-0.14-0.13-0.13-0.03-0.14
EPS (Diluted)
-0.34-0.37-0.32-0.34-0.38-0.36-0.28-0.26-0.32-0.29-0.64-0.220.01-1.44-0.14-0.13-0.13-0.03-0.14
Shares Outstanding
198.57M204.14M222.29M224.50M225.12M224.55M242.03M250.07M255.00M253.63M269.58M272.38M272.92M274.49M296.86M300.16M300.84M299.96M305.82M310.65M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
198.57M204.14M222.29M224.50M225.12M224.55M242.03M250.07M255.00M253.63M269.58M272.38M272.92M288.37M296.86M300.16M300.84M299.96M305.82M310.65M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
220.98M224.33M224.76M225.92M226.50M249.80M250.47M258.37M267.74M272.28M272.49M273.81M294.42M300.04M300.35M301.85M301.96M310.49M310.81M
EBITDA
-64.68M-75.25M-65.65M-72.27M-84.52M-88.50M-70.35M-79.59M-84.53M-78.12M-172.35M-59.88M-150.16M-423.80M-42.19M-36.42M-38.45M-6.16M-42.29M
Interest ExpensesInt Expense
3.48M3.70M3.68M3.66M3.65M3.63M3.55M3.59M3.57M3.58M3.54M3.54M2.76M1.74M1.74M1.74M1.74M1.74M2.11M
Tax Rate
-1.72%13.80%0.87%11.76%0.07%-0.08%-1.02%-0.50%-2.27%-0.13%